Corcept Therapeutics (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $79.91 --0%
EPS Growth %: -96.6%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -96.6%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $13.9 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
- Benchmark Starts Boyd Gaming (BYD) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
